Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.47 |
| ▸ | RELA | Q04206 | 4/20 | 0.46 |
| ▸ | CASP2 | P42575 | 1/20 | 0.45 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.43 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.42 |
| ▸ | RRM1 | P23921 | 1/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.41 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1037232 | 1.00 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL8723696 | 0.91 | SLC6A5 (0.55) | SLC6A5CASP2NAAAPAOXGNAI3 | |
| SCHEMBL27971595 | 0.88 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL27817058 | 0.88 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL28264890 | 0.88 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL27490298 | 0.88 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL9290507 | 0.87 | NAAA (0.50) | CASP2NAAAPAOXDNM1EPHX1 | |
| SCHEMBL19040774 | 0.87 | CASP2 (0.58) | CASP2NAAADNM1EPHX1 | |
| SCHEMBL28817375 | 0.86 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL28093185 | 0.86 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674431-A1 | LIPID NANOPARTICLES, PHARMACEUTICAL COMPOSITION, AND PRODUCTION METHOD FOR LIPID NANOPARTICLES | Japan Science and Technology Agency (JP) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024181580-A1 | LIPID NANOPARTICLES, PHARMACEUTICAL COMPOSITION, AND PRODUCTION METHOD FOR LIPID NANOPARTICLES | 国立研究開発法人科学技術振興機構 | 2024-09-06 | — | — | WO | disclosed |
| EP-1812074-B1 | INTRACELLULAR PEPTIDE DELIVERY | NITTO DENKO CORP (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-20100297023-A1 | Lipid | IMUTHES LIMITED UNIVERSITY OF THE WITWATERSRAND | 2010-11-25 | — | — | US | disclosed |
| EP-2124895-A2 | LIPIDS AND THEIR USE AS NON-VIRAL DELIVERY VEHICLE | IMUTHES LIMITED (GB) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008078102-A2 | LIPIDS AND THEIR USE AS NON-VIRAL DELIVERY VEHICLE | IMUTHES LIMITED (GB) | 2008-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297023-A1 | Lipid | NR1H2, NR1H3, NR1H4 | SLC6A5 1426/4885RELA 3385/4885CASP2 2631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.